Home » Topics » Briefs » Other news to note

Other news to note
RSS

Abide Therapeutics gives an overview of their serine hydrolase-targeting products

Jan. 17, 2018

Rxi Pharmaceuticals to focus on immuno-oncology

Jan. 17, 2018

Jounce Therapeutics reviews its next-generation immunotherapy pipeline

Jan. 17, 2018

InflaRx presents company and pipeline overview

Jan. 16, 2018

Prolong Pharmaceuticals gives update on ongoing projects

Jan. 16, 2018

GeneDx enters research collaboration with the Radboud University

Jan. 15, 2018

AnaptysBio: treating severe inflammatory diseases

Jan. 15, 2018

Aviragen reiterates support for pending merger with Vaxart

Jan. 12, 2018

Ligand and Glenmark enter OmniAb license agreement

Jan. 12, 2018

HedgePath to receive new investment from Mayne Pharma

Jan. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...